Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma

NCT00028600 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma
Plasma Cell Neoplasm

Interventions

BIOLOGICAL: filgrastim
BIOLOGICAL: CD34+ cells
DRUG: cyclophosphamide
DRUG: fludarabine phosphate
DRUG: melphalan
DRUG: methotrexate
DRUG: tacrolimus

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]